{"id":288,"date":"2020-10-05T10:00:00","date_gmt":"2020-10-05T01:00:00","guid":{"rendered":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/2017\/06\/20\/201729\/"},"modified":"2020-10-05T16:08:37","modified_gmt":"2020-10-05T07:08:37","slug":"201729","status":"publish","type":"post","link":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/achievement\/20201005288\/","title":{"rendered":"2017\u5e74\uff08\u5e73\u621029\u5e74\u5ea6\uff09\u306e\u7814\u7a76\u696d\u7e3e"},"content":{"rendered":"

A. \u8ad6\u6587<\/h3>\n

\u3010\u8457\u66f8\u3011<\/h4>\n
    <\/ol>\n

    \u3010\u539f\u8457\u3011<\/h4>\n
      \n
    1. Mori S, Yoshitama T, Hidaka T, Sakai F, Hasegawa M, Hashiba Y, Suematsu E, Tatsukawa H, Mizokami A, Yoshizawa S, Hirakata N, Ueki Y. Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan. PLoS One. 2017; 12(6):e0179179. (Jun)<\/li>\n
    2. Kuramitsu M, Sekizuka T, Yamochi T, Firouzi S, Sato T, Umeki K, Sasaki D, Hasegawa H, Kubota R, Sobata R, Matsumoto C, Kaneko N, Momose H, Araki K, Saito M, Nosaka K, Utsunomiya A, Koh K-R, Ogata M, Uchimaru K, Iwanaga M, Sagara Y, Yamano Y, Okayama A, Miura K, Satake M, Saito S, Itabashi K, Yamaguchi K, Kuroda M, Watanabe T, Okuma K, Hamaguchi I. Proviral Features of Human T Cell Leukemia Virus Type 1 in Carriers with Indeterminate Western Blot Analysis Results. J Clin Microbiol. 2017 ;55(9):2838-2849. (Sep) doi: 10.1128\/JCM.00659-17.<\/li>\n
    3. Takajo I, Yamada A, Umeki K, Saeki Y, Hashikura Y, Yamamoto I, Umekita K, Urayama-Kawano M, Yamasaki S, Taniguchi T, Misawa N, Okayama A. Development of a simple and practical method of discrimination between Vibrio furnissii and V. fluvialis based on single-nucleotide polymorphisms of 16S rRNA genes observed in V. furnissii but not in V. fluvialis. J Microbiol Methods. 2017; 144: 22-28. (Oct 27)<\/li>\n
    4. Hidaka T, Hashiba Y, Kubo K, Kai Y, Maeda K. Leukocytapheresis in rheumatoid arthritis. Transfus Apher Sci. 2017; 56(5):698-702. (Oct)<\/li>\n
    5. Suzuki T, Fukui S, Umekita K, Miyamoto J, Umeda M, Nishino A, Okada A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Fujikawa K, Aramaki T, Mizokami A, Matsuoka N, Ueki Y, Eguchi K, Sato S, Hidaka T, Origuchi T, Okayama A, Kawakami A, Nakamura H. Attenuated effectiveness of tumor necrosis factor inhibitors for anti-human T-lymphotropic virus type 1 antibody-positive rheumatoid arthritis. Arthritis Rheumatol. 2018 ;70(7):1014-1021. (Jul) 2018 Feb 22. doi: 10.1002\/art.40461. Epub 2018 May 25.<\/li>\n
    6. \u65e5\u9ad8\u5229\u5f66, \u6a4b\u5834\u5f25\u751f, \u4e45\u4fdd\u548c\u7fa9, \u9ed2\u7530\u5b8f, \u524d\u7530\u5553\u4e00. \u5f53\u9662\u306b\u304a\u3051\u308b\u9ad8\u9f62\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u306b\u5bfe\u3059\u308b\u30c8\u30b7\u30ea\u30ba\u30de\u30d6\u306e\u6cbb\u7642\u52b9\u679c\u3068\u5b89\u5168\u6027. \u81e8\u5e8a\u30ea\u30a6\u30de\u30c1. 2018; 30: 38-50.(3\u6708)<\/li>\n<\/ol>\n

      \u3010\u75c7\u4f8b\u5831\u544a\uff08\u8ad6\u6587\uff09\u3011<\/h4>\n
        \n
      1. Hashiba Y, Hidaka T, Umekita K, Nishi E, Kai Y, Kubo K, Okayama A. Remission of chronic type ATL in a patient with rheumatoid arthritis after withdrawing methotrexate and infliximab combination therapy: a case report. Modern Rheumatology Case Reports. (Online) Published online: 2017 (Sep)<\/li>\n
      2. \u529b\u6b66\u771f\u592e, \u6885\u5317\u90a6\u5f66, \u6960\u5143\u898f\u751f, \u5ca9\u5c3e\u6d69\u662d, \u76f8\u6fa4\u5f69\u5b50, \u677e\u7530\u57fa\u5f18, \u4e45\u4fdd\u548c\u7fa9, \u4eee\u5c4b\u88d5\u7f8e, \u5bae\u5185\u4fca\u4e00, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u591a\u767a\u8133\u6897\u585e\u3092\u6765\u3057\u305f\u6cbb\u7642\u62b5\u6297\u6027\u5de8\u7d30\u80de\u6027\u52d5\u8108\u708e\u306e1\u4f8b. \u4e5d\u5dde\u30ea\u30a6\u30de\u30c1. 2017; 37(2): 125-131. (9\u6708)<\/li>\n
      3. \u4eca\u4e95\u7f8e\u91cc, \u6a4b\u5009\u60a0\u8f1d, \u6885\u6728\u4e00\u7f8e, \u5c71\u672c\u6210\u90ce, \u6885\u5317\u4f73\u5b50, \u76db\u53e3\u6df8\u9999, \u4e45\u5bcc\u6728\u5eb8\u5b50, \u5ca1\u5c71\u662d\u5f66. \u5168\u81ea\u52d5\u8840\u6db2\u691c\u67fb\u88c5\u7f6e\u306e\u7570\u5e38\u30d1\u30bf\u30fc\u30f3\u3092\u5951\u6a5f\u306b\u8840\u6db2\u5857\u62b9\u6a19\u672c\u306e\u93e1\u691c\u3067\u8a3a\u65ad\u304c\u5c0e\u304b\u308c\u305f\u5f62\u8cea\u7d30\u80de\u767d\u8840\u75c5. \u533b\u5b66\u691c\u67fb. 2017; 66(6): 715-720. (11\u6708)<\/li>\n
      4. \u9ad8\u6728\u899a, \u6a4b\u5009\u60a0\u8f1d, \u6885\u6728\u4e00\u7f8e, \u4eca\u4e95\u7f8e\u91cc, \u660e\u5229\u7f8e\u91cc, \u7dd2\u65b9\u967d\u4e00, \u5c71\u672c\u6210\u90ce, \u4e45\u5bcc\u6728\u5eb8\u5b50, \u5ca1\u5c71\u662d\u5f66. Neutrophil alkaline phosphatase \u6d3b\u6027\u306e\u4f4e\u4e0b\u3068BCR\/ABL1\u907a\u4f1d\u5b50\u89e3\u6790\u3067\u8a3a\u65ad\u3055\u308c\u305fmicro BCR\/ABL1(e19a2)\u967d\u6027\u6162\u6027\u9aa8\u9ac4\u6027\u767d\u8840\u75c5. \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u96d1\u8a8c. 2017; 18(3): 394-401. (11\u6708)<\/li>\n
      5. Oryoji D, Ono N, Himeji D, Yoshihiro K, Kai Y, Matsuda M, Tsukamoto H, Ueda A. Sudden Respiratory Failure due to Tracheobronchomalacia by Relapsing Polychondritis, Successfully Rescued by Multiple Metallic Stenting and Tracheostomy. Intern Med. 2017; 56(24): 3369-3372.( Dec 15) doi: 10.2169\/internalmedicine.8778-16.<\/li>\n
      6. \u5bae\u5185\u4fca\u4e00, \u677e\u7530\u57fa\u5f18, \u9577\u53cb\u5b89\u5f18. \u3073\u307e\u3093\u6027\u6c4e\u7d30\u6c17\u7ba1\u652f\u708e\u3068\u8a3a\u65ad\u3055\u308c\u3066\u3044\u305f\u539f\u767a\u6027\u7dda\u6bdb\u6a5f\u80fd\u4e0d\u5168\u75c7. \u6c17\u7ba1\u652f\u5b66. 2018; 40(1): 31-35. (1\u6708)<\/li>\n
      7. Takajo I, Umekita K, Ikei Y, Oshima K, Okayama A. Adult T-cell Leukemia\/Lymphoma as a Methotrexate-associated Lymphoproliferative Disorder in a Patient with Rheumatoid Arthritis – A Case Report. Intern Med. 2018 ;57(14): 2071-2075. (Jul 15) 2018 Feb 28. doi: 10.2169\/internalmedicine.0308-17. [Epub ahead of print]<\/li>\n
      8. Kawaguchi T, Himeji D, Kawano N, Shimao Y, Marutsuka K. Endobronchial Mucosa-associated Lymphoid Tissue Lymphoma: A Report of Two Cases and a Review of the Literature. Intern Med. 2018; 57(15): 2233-2236. (Aug 1) 2018 Mar 9. doi: 10.2169\/internalmedicine.0150-17. [Epub ahead of print]<\/li>\n
      9. \u9ad8\u57ce\u4e00\u90ce, \u8352\u6b66\u821e, \u798f\u7530\u771f\u5f13, \u5e73\u539f\u5eb7\u5bff, \u4f50\u4f2f\u88d5\u4e8c, \u5ca1\u5c71\u662d\u5f66. \u6bcd\u5150\u7d50\u6838\u611f\u67d3\u4f8b\u306e\u9662\u5185\u611f\u67d3\u5bfe\u7b56. \u74b0\u5883\u611f\u67d3\u8a8c. 2018; 33(2): 81-86. (Online3\u6708)<\/li>\n<\/ol>\n

        \u3010\u7dcf\u8aac\u3011<\/h4>\n
          \n
        1. \u6885\u5317\u90a6\u5f66. \u6cbb\u7642\u62b5\u6297\u6027\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u304a\u3051\u308bHTLV-1\u611f\u67d3\u306e\u5f71\u97ff. \u30a2\u30ec\u30eb\u30ae\u30fc\u306e\u81e8\u5e8a. 2017; 37(5): 86-91.<\/li>\n
        2. \u6885\u5317\u90a6\u5f66. HTLV-1\u967d\u6027\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u304a\u3051\u308bTNF\u963b\u5bb3\u7642\u6cd5. \u30a2\u30ec\u30eb\u30ae\u30fc\u306e\u81e8\u5e8a. 2017; 37(7): 73-78.<\/li>\n
        3. \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. HTLV-1\u611f\u67d3\u3068\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u8a3a\u7642. \u30ea\u30a6\u30de\u30c1\u79d1. 2017; 58(3): 340-346.<\/li>\n
        4. \u9ad8\u57ce\u4e00\u90ce. \u91cd\u75c7\u71b1\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\u5019\u7fa4(Severe\u3000fever with thrombocytopenia syndrome : SFTS)\u306b\u3064\u3044\u3066. \u5bae\u5d0e\u770c\u5185\u79d1\u533b\u4f1a\u8a8c. 2017; 92: 5-7. (10\u6708)<\/li>\n<\/ol>\n

          –<\/p>\n

          \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/a><\/div>\n

          B. \u767a\u8868<\/h3>\n

          \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/h4>\n
            \n
          1. \u5c71\u7530\u660e\u8f1d, \u5c71\u672c\u6210\u90ce, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u30b0\u30e9\u30e0\u67d3\u8272\u3068Laser Micro Dissection\u6cd5\u3092\u7d44\u307f\u5408\u308f\u305b\u305f\u7d30\u83cc\u6838\u9178\u8a3a\u65ad\u6cd5. \u7b2c91\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u8b1b\u6f14\u4f1a \u7b2c65\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u5408\u540c\u5b66\u4f1a. \u4e00\u822c\u6f14\u984c \u907a\u4f1d\u5b50\u691c\u67fb\u2460\u300002-136. 2017. (4\u67086-8\u65e5\uff087\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u65b0\u5bbf\u533a, \u4eac\u738b\u30d7\u30e9\u30b6\u30db\u30c6\u30eb)<\/li>\n
          2. \u4fdd\u7530\u548c\u91cc, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u91cd\u75c7\u71b1\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\u5019\u7fa4(SFTS)\u30a6\u30a4\u30eb\u30b9\u6838\u86cb\u767d\u8cea\u306e\u767a\u73fe\u3068\u6297\u4f53\u691c\u51fa\u6cd5\u306e\u691c\u8a0e. \u7b2c91\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u8b1b\u6f14\u4f1a \u7b2c65\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u5408\u540c\u5b66\u4f1a. \u4e00\u822c\u6f14\u984c \u907a\u4f1d\u5b50\u691c\u67fb\u2461\u300002-143. 2017. (4\u67086-8\u65e5\uff087\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u65b0\u5bbf\u533a, \u4eac\u738b\u30d7\u30e9\u30b6\u30db\u30c6\u30eb)<\/li>\n
          3. \u677e\u7530\u57fa\u5f18, \u9ad8\u57ce\u4e00\u90ce, \u5ca9\u5c3e\u6d69\u662d, \u6cb3\u91ce\u5f69\u5b50, \u4eee\u5c4b\u88d5\u7f8e, \u5bae\u5185\u4fca\u4e00, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u751f\u7269\u5b66\u7684\u88fd\u5264\u6cbb\u7642\u4e2d\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u304a\u3051\u308b\u5165\u9662\u52a0\u7642\u3092\u8981\u3057\u305f\u611f\u67d3\u75c7\u306e\u691c\u8a0e. \u7b2c91\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u8b1b\u6f14\u4f1a \u7b2c65\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u5408\u540c\u5b66\u4f1a. \u4e00\u822c\u6f14\u984c(\u30dd\u30b9\u30bf\u30fc)\u65e5\u548c\u898b\u611f\u67d3\u75c7\u2461 P3-072. 2017. (4\u67086-8\u65e5\uff088\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u65b0\u5bbf\u533a, \u4eac\u738b\u30d7\u30e9\u30b6\u30db\u30c6\u30eb)<\/li>\n
          4. \u6ff1\u5ee3\u53cb\u83ef, \u5bae\u5185\u4fca\u4e00, \u9ed2\u6728\u5efa\u543e, \u6a4b\u672c\u795e\u5948, \u576a\u5185\u62e1\u4f38, \u5ca1\u5c71\u662d\u5f66, \u5c0f\u677e\u5f18\u5e78. \u8996\u795e\u7d4c\u75c5\u5909\u3092\u307f\u3068\u3081\u306a\u3044\u6297\u30a2\u30af\u30a2\u30dd\u30ea\u30f34\u6297\u4f53\u967d\u6027\u30b7\u30a7\u30fc\u30b0\u30ec\u30f3\u75c7\u5019\u7fa4\u306e1\u4f8b. \u7b2c114\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u8b1b\u6f14\u4f1a \u533b\u5b66\u751f\u30fb\u7814\u4fee\u533b\u306e\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u3053\u3068\u306f\u3058\u3081. \u30a2\u30ec\u30eb\u30ae\u30fc\u30fb\u81a0\u539f\u75c5\u2461\u3000247. 2017. (4\u670815\u65e5, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
          5. \u9234\u6728\u8cb4\u4e45, \u6885\u5317\u90a6\u5f66, \u798f\u4e95\u7fd4\u4e00, \u5ca9\u672c\u76f4\u6a39, \u4e2d\u6751\u82f1\u6a39, \u5ca1\u7530\u899a\u4e08, \u85e4\u5ddd\u656c\u592a, \u8352\u7267\u4fca\u5e78, \u690d\u6728\u5e78\u5b5d, \u6c5f\u53e3\u52dd\u7f8e, \u585a\u7530\u654f\u662d, \u576a\u4e95\u96c5\u5f66, \u677e\u5ca1\u76f4\u6a39, \u4e2d\u5cf6\u5b97\u654f, \u65e5\u9ad8\u5229\u5f66, \u5ca1\u5c71\u662d\u5f66, \u5ddd\u4e0a\u7d14. \u6297HTLV-1\u6297\u4f53\u306e\u6709\u7121\u304c\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u5bfe\u3059\u308bTocilizumab\u7642\u6cd5\u3078\u306e\u53cd\u5fdc\u6027\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e\uff1a\u591a\u65bd\u8a2d\u5171\u540c\u7814\u7a76. \u7b2c61\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u30dd\u30b9\u30bf\u30fc\u30bb\u30c3\u30b7\u30e7\u30f3\u3000P1-111. 2017. (4\u670820-22\u65e5\uff0820\u65e5\u767a\u8868\uff09,\u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u798f\u5ca1\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
          6. \u5185\u85e4\u6566, \u4e0a\u7530\u5c1a\u9756, \u5ddd\u53e3\u525b. \u30b9\u30c6\u30ed\u30a4\u30c9\u30d1\u30eb\u30b9\u7642\u6cd5\u304c\u594f\u529f\u3057\u305f\u80ba\u75c5\u5909\u5408\u4f75Sweet\u75c7\u5019\u7fa4\u306e1\u4f8b. \u7b2c61\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u30dd\u30b9\u30bf\u30fc\u30bb\u30c3\u30b7\u30e7\u30f3\u3000P1-272. 2017. (4\u670820-22\u65e5\uff0820\u65e5\u767a\u8868\uff09,\u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u798f\u5ca1\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
          7. \u6a4b\u5834\u5f25\u751f, \u897f\u82f1\u5b50, \u7532\u6590\u6cf0\u6587, \u9ed2\u7530\u5b8f, \u65e5\u9ad8\u5229\u5f66. \u5f53\u9662\u3067\u306e\u9ad8\u9f62\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u306b\u304a\u3051\u308b\u30c8\u30b7\u30ea\u30ba\u30de\u30d6\u4f7f\u7528\u6210\u7e3e. \u7b2c61\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. Workshop\u3000W43-2. 2017. (4\u670820-22\u65e5\uff0821\u65e5\u767a\u8868\uff09,\u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u798f\u5ca1\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
          8. \u5ca9\u5c3e\u6d69\u662d, \u6885\u5317\u90a6\u5f66, \u5c0f\u6751\u771f\u592e, \u6cb3\u91ce\u5f69\u5b50, \u4e45\u4fdd\u548c\u7fa9, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u514d\u75ab\u6291\u5236\u7642\u6cd5\u4e2d\u306e\u81a0\u539f\u75c5\u60a3\u8005\u306b\u304a\u3051\u308b\u30cb\u30e5\u30fc\u30e2\u30b7\u30b9\u30c1\u30b9\u80ba\u708e\u306b\u5bfe\u3059\u308bST\u5408\u5264\u4e88\u9632\u5185\u670d\u306e\u7528\u6cd5\u3068\u7d99\u7d9a\u7387\u306e\u691c\u8a0e. \u7b2c61\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. Workshop\u3000W52-4. 2017. (4\u670820-22\u65e5\uff0821\u65e5\u767a\u8868\uff09,\u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u798f\u5ca1\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
          9. \u65e5\u9ad8\u5229\u5f66, \u6a4b\u5834\u5f25\u751f, \u897f\u82f1\u5b50, \u7532\u6590\u6cf0\u6587, \u9ed2\u7530\u5b8f, \u4e45\u4fdd\u548c\u7fa9, \u5ca1\u5c71\u662d\u5f66. \u5f53\u9662\u306b\u304a\u3051\u308b\u30a4\u30f3\u30d5\u30ea\u30ad\u30b7\u30de\u30d6\u5897\u91cf\u30fb\u77ed\u7e2e\u6cbb\u7642\u306e\u5bdb\u89e3\u4f11\u85ac\u57fa\u6e96\u3092\u9054\u6210\u3067\u304d\u308b\u80cc\u666f\u56e0\u5b50\u306e\u691c\u8a0e. \u7b2c61\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. Workshop\u3000W61-2. 2017. (4\u670820-22\u65e5\uff0822\u65e5\u767a\u8868\uff09,\u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u798f\u5ca1\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
          10. Umekita K, Miyauchi S, Kubo K, Matsuda M, Kawano A, Iwao K, Komura M, Kariya Y, Takajo K, Takajo I, Nagatomo Y, Okayama A. Exosomes \uff44erived \uff46rom HTLV-1 Infected \uff43ell Enhances\u3000IFN-\u03b3\u3000Induced\u3000Expression of CXCL10 in Rheumatoid Arthritis Synovial Fibroblasts. \u7b2c61\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. International Concurrent Workshop\u3000ICW-18-1. 2017. (4\u670820-22\u65e5\uff0822\u65e5\u767a\u8868\uff09,\u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u798f\u5ca1\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
          11. \u65e5\u9ad8\u5229\u5f66, \u6a4b\u5834\u5f25\u751f, \u897f\u82f1\u5b50, \u7532\u6590\u6cf0\u6587, \u9ed2\u7530\u5b8f, \u4e45\u4fdd\u548c\u7fa9, \u5ca1\u5c71\u662d\u5f66. \u5f53\u9662\u306b\u304a\u3051\u308b\u30a4\u30b0\u30e9\u30c1\u30e2\u30c9\u306e\u6cbb\u7642\u52b9\u679c\u3068\u5bdb\u89e3\u3092\u9054\u6210\u3067\u304d\u308b\u80cc\u666f\u56e0\u5b50\u306e\u691c\u8a0e. \u7b2c61\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. Workshop\u3000W96-2. 2017. (4\u670820-22\u65e5\uff0822\u65e5\u767a\u8868\uff09,\u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u798f\u5ca1\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
          12. \u6cb3\u91ce\u5f69\u5b50, \u6885\u5317\u90a6\u5f66, \u5c0f\u6751\u771f\u592e, \u5ca9\u5c3e\u6d69\u662d, \u677e\u7530\u57fa\u5f18, \u4e45\u4fdd\u548c\u7fa9, \u5bae\u5185\u4fca\u4e00, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u591a\u767a\u6027\u7b4b\u708e\/\u76ae\u819a\u7b4b\u708e\u306b\u5408\u4f75\u3059\u308b\u9593\u8cea\u6027\u80ba\u708e\u3068\u8840\u6db2\u51dd\u56fa\u7570\u5e38\u306b\u95a2\u3059\u308b\u691c\u8a0e. \u7b2c61\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u30dd\u30b9\u30bf\u30fc\u30bb\u30c3\u30b7\u30e7\u30f3\u3000P3-185. 2017. (4\u670820-22\u65e5\uff0822\u65e5\u767a\u8868\uff09,\u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u798f\u5ca1\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
          13. \u9577\u53cb\u5b89\u5f18, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u4e45\u4fdd\u548c\u7fa9, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u80f8\u90e8\u306b\u75c5\u5909\u304c\u898b\u3089\u308c\u305fIgG4\u95a2\u9023\u75be\u60a3\u306e4\u4f8b. \u7b2c57\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. \u30dd\u30b9\u30bf\u30fc\u300c\u75c7\u4f8b\u30fb\u305d\u306e\u4ed61\u300d PP657. 2017. (4\u670821-23\u65e5\uff0822\u65e5\u767a\u8868\uff09,\u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
          14. Umekita K, Miyauchi S, Kubo K, Kawano A, Iwao K, Komura M, Matsuda M, Takajo I, Nomura H, Nagatomo Y, Okayama A. HUMAN T CELL LEUKEMIA VIRUS TYPE 1 (HTLV-1) EXACERBATES RHEUMATOID ARTHRITIS; EXOSOMES AND IFN-GAMMA DERIVED FROM HTLV-1 INFECTED CELLS ENHANCE THE INFLAMMATORY RESPONSE OF RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS VIA PATTERN RECOGNITION RECEPTOR, RIG-I. EULAR 2017. Innate immunity in rheumatic diseases AB0021. 2017. (6\u670814-17\u65e5, Madrid, Spain)<\/li>\n
          15. \u6885\u5317\u90a6\u5f66, \u6a4b\u5834\u5f25\u751f, \u4eee\u5c4b\u88d5\u7f8e, \u5bae\u5185\u4fca\u4e00, \u6885\u6728\u4e00\u7f8e, \u5c71\u672c\u6210\u90ce, \u91ce\u6751\u5275, \u6a4b\u5009\u60a0\u8f1d, \u677e\u7530\u57fa\u5f18, \u4e45\u4fdd\u548c\u7fa9, \u76f8\u6fa4\u5f69\u5b50, \u9ad8\u57ce\u4e00\u90ce, \u65e5\u9ad8\u5229\u5f66, \u5ca1\u5c71\u662d\u5f66. \u5bae\u5d0e\u770cHTLV-1\u967d\u6027\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u30b3\u30db\u30fc\u30c8\u306b\u304a\u3051\u308bATL\u767a\u75c7\u30ea\u30b9\u30af\u56e0\u5b50\u306e\u691c\u8a0e. \u7b2c4\u56de\u65e5\u672cHTLV-1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. Session 6 \u75ab\u5b66, O-33. 2017. (8\u670818-20\u65e5\uff0820\u65e5\u767a\u8868\uff09,\u5927\u962a\u5e9c\u679a\u65b9\u5e02, \u95a2\u897f\u533b\u79d1\u5927\u5b66)<\/li>\n
          16. \u9ad8\u57ce\u4e00\u90ce, \u5ddd\u7530\u5343\u7d18, \u529b\u6b66\u96c4\u5e79, \u529b\u6b66\u771f\u592e, \u5ca9\u5c3e\u6d69\u662d, \u76f8\u6fa4\u5f69\u5b50, \u4eee\u5c4b\u88d5\u7f8e, \u5ddd\u53e3\u525b, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u6c60\u4e95\u7fa9\u5f66, \u5ca1\u5c71\u662d\u5f66. \u30e1\u30c8\u30c8\u30ec\u30ad\u30b5\u30fc\u30c8\u95a2\u9023\u30ea\u30f3\u30d1\u5897\u6b96\u6027\u75be\u60a3\u306e\u81ea\u7136\u5bdb\u89e3\u5f8c\u306bATL\u3092\u767a\u75c7\u3057\u305f\u3068\u8003\u3048\u3089\u308c\u305f\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306e1\u4f8b. \u7b2c4\u56de\u65e5\u672cHTLV-1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u30dd\u30b9\u30bf\u30fc\u3000P15. 2017. (8\u670818-20\u65e5\uff0820\u65e5\u767a\u8868\uff09,\u5927\u962a\u5e9c\u679a\u65b9\u5e02, \u95a2\u897f\u533b\u79d1\u5927\u5b66)<\/li>\n
          17. \u65e5\u9ad8\u5229\u5f66, \u4e45\u4fdd\u548c\u7fa9, \u6a4b\u5834\u5f25\u751f, \u7532\u6590\u6cf0\u6587, \u9ed2\u7530\u5b8f. \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u5bfe\u3059\u308b\u751f\u7269\u5b66\u7684\u88fd\u5264\u6cbb\u7642\u306e\u5f53\u9662\u306b\u304a\u3051\u308b\u5b89\u5168\u5bfe\u7b56. \u7b2c54\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. S-1-1. 2017. (9\u67082-3\u65e5\uff082\u65e5\u767a\u8868\uff09,\u798f\u5ca1\u770c\u5317\u4e5d\u5dde\u5e02, \u5317\u4e5d\u5dde\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
          18. \u68ee\u4fca\u8f14, \u5409\u7389\u73e0\u7f8e, \u65e5\u9ad8\u5229\u5f66, \u6a4b\u5834\u5f25\u751f, \u9152\u4e95\u6587\u548c, \u9577\u8c37\u5ddd\u745e\u679d, \u672b\u677e\u6804\u4e00, \u7acb\u5ddd\u88d5\u53f2, \u6e9d\u4e0a\u660e\u6210, \u5e73\u65b9\u5c1a\u4e4b, \u690d\u6728\u5e78\u5b5d. RA\u306b\u5bfe\u3059\u308b\u751f\u7269\u5b66\u7684\u88fd\u5264\u6cbb\u7642\u306b\u95a2\u9023\u3059\u308b\u611f\u67d3\u75c7\u767a\u751f\u983b\u5ea6\u306b\u88fd\u5264\u9593\u306e\u9055\u3044\u304c\u3042\u308b\u304b\uff1f\uff1a\u591a\u65bd\u8a2d\u5f8c\u308d\u5411\u304d\u7814\u7a76. \u7b2c54\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. S-1-8. 2017. (9\u67082-3\u65e5\uff082\u65e5\u767a\u8868\uff09,\u798f\u5ca1\u770c\u5317\u4e5d\u5dde\u5e02, \u5317\u4e5d\u5dde\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
          19. \u56f3\u5e2b\u572d\u4e00, \u65e5\u91ce\u4e9c\u7d00\u5b50, \u82a6\u6fa4\u9ebb\u571f\u9999, \u5ca1\u5c71\u4eac\u5b50, \u77e2\u91ce\u662d\u4ee3, \u6771\u539f\u7f8e\u7531\u7d00, \u6a4b\u5834\u5f25\u751f, \u4e45\u4fdd\u548c\u7fa9, \u7532\u6590\u6cf0\u6587, \u65e5\u9ad8\u5229\u5f66. \u30a2\u30c0\u30ea\u30e0\u30de\u30d6\u65b0\u898f\u88fd\u5264\u3078\u306e\u5909\u66f4\u306b\u4f34\u3046\u6ce8\u5c04\u6642\u75bc\u75db\u306e\u8efd\u6e1b\u306b\u95a2\u3059\u308b\u691c\u8a0e. \u7b2c54\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. O-2-4. 2017. (9\u67082-3\u65e5\uff082\u65e5\u767a\u8868\uff09,\u798f\u5ca1\u770c\u5317\u4e5d\u5dde\u5e02, \u5317\u4e5d\u5dde\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
          20. \u5ddd\u7530\u5343\u7d18, \u5bae\u5185\u4fca\u4e00, \u5ca9\u5c3e\u6d69\u662d,\u529b\u6b66\u96c4\u5e79, \u529b\u6b66\u771f\u592e, \u76f8\u6fa4\u5f69\u5b50, \u677e\u7530\u57fa\u5f18, \u5ddd\u53e3\u525b, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66, \u5c71\u4e0b\u7be4, \u4f50\u85e4\u52c7\u4e00\u90ce, \u6d45\u7530\u7950\u58eb\u90ce. \u524d\u7e26\u9694\u306e\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u3092\u5408\u4f75\u3057\u305f\u30b7\u30a7\u30fc\u30b0\u30ec\u30f3\u75c7\u5019\u7fa4\u306e1\u4f8b. \u7b2c54\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. O-6-6. 2017. (9\u67082-3\u65e5\uff082\u65e5\u767a\u8868\uff09,\u798f\u5ca1\u770c\u5317\u4e5d\u5dde\u5e02, \u5317\u4e5d\u5dde\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
          21. \u5ca9\u5c3e\u6d69\u662d, \u6885\u5317\u90a6\u5f66, \u5ddd\u7530\u5343\u7d18, \u529b\u6b66\u96c4\u5e79, \u529b\u6b66\u771f\u592e, \u76f8\u6fa4\u5f69\u5b50, \u677e\u7530\u57fa\u5f18, \u5ddd\u53e3\u525b, \u5bae\u5185\u4fca\u4e00, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66, \u524d\u5ddd\u548c\u4e5f, \u6d45\u7530\u7950\u58eb\u90ce, \u8d64\u6728\u771f\u7531\u7f8e, \u7247\u5ca1\u5bdb\u7ae0. IgG4\u95a2\u9023\u75be\u60a3\u3068\u8003\u3048\u3089\u308c\u305f\u56de\u8178\u672b\u7aef\u90e8\u9686\u8d77\u6027\u75c5\u5909\u306e1\u4f8b. \u7b2c54\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. O-8-2. 2017. (9\u67082-3\u65e5\uff083\u65e5\u767a\u8868\uff09,\u798f\u5ca1\u770c\u5317\u4e5d\u5dde\u5e02, \u5317\u4e5d\u5dde\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
          22. \u9ad8\u57ce\u4e00\u90ce, \u5ddd\u7530\u5343\u7d18, \u529b\u6b66\u96c4\u5e79, \u529b\u6b66\u771f\u592e, \u5ca9\u5c3e\u6d69\u662d, \u76f8\u6fa4\u5f69\u5b50, \u4eee\u5c4b\u88d5\u7f8e, \u5ddd\u53e3\u525b, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u6c60\u4e95\u7fa9\u5f66, \u5ca1\u5c71\u662d\u5f66. MTX-LPD\u81ea\u7136\u5bdb\u89e3\u5f8cATL\u3092\u767a\u75c7\u3057\u305fHTLV-1\u967d\u6027\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1. \u7b2c54\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. O-10-3. 2017. (9\u67082-3\u65e5\uff083\u65e5\u767a\u8868\uff09,\u798f\u5ca1\u770c\u5317\u4e5d\u5dde\u5e02, \u5317\u4e5d\u5dde\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
          23. \u5ddd\u53e3\u525b, \u59eb\u8def\u5927\u8f14. Raynaud\u73fe\u8c61\u3092\u5408\u4f75\u3057\u305f\u98df\u9053\u764c\u306e1\u4f8b. \u7b2c15\u56de\u65e5\u672c\u75c5\u9662\u7dcf\u5408\u8a3a\u7642\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a. \u30dd\u30b9\u30bf\u30fc\u30bb\u30c3\u30b7\u30e7\u30f3 P-001. 2017. (9\u670814-15\u65e5\uff0814\u65e5\u767a\u8868\uff09,\u5343\u8449\u770c\u6d66\u5b89\u5e02, \u30c7\u30a3\u30ba\u30cb\u30fc\u30a2\u30f3\u30d0\u30b5\u30c0\u30fc\u30db\u30c6\u30eb)<\/li>\n
          24. \u6728\u6751\u8ce2\u4fca, \u5ca9\u5c3e\u6d69\u662d, \u9ad8\u57ce\u4e00\u90ce, \u5ddd\u7530\u5343\u7d18, \u529b\u6b66\u96c4\u5e79, \u5c0f\u6751\u771f\u592e, \u6cb3\u91ce\u5f69\u5b50, \u5ddd\u53e3\u525b, \u677e\u7530\u57fa\u5f18, \u6885\u5317\u90a6\u5f66, \u5bae\u5185\u4fca\u4e00, \u5ca1\u5c71\u662d\u5f66. \u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u691c\u67fb\u967d\u6027\u5f8c\u306b\u6025\u6027HIV\u611f\u67d3\u75c7\u3068\u8a3a\u65ad\u3055\u308c\u305f1\u4f8b. \u7b2c87\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c60\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c65\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a. \u7814\u4fee\u533b\u30bb\u30c3\u30b7\u30e7\u30f31\u300027. 2017. (10\u670826-28\u65e5\uff0826\u65e5\u767a\u8868\uff09, \u9577\u5d0e\u770c\u9577\u5d0e\u5e02, \u9577\u5d0e\u30d6\u30ea\u30c3\u30af\u30db\u30fc\u30eb)<\/li>\n
          25. \u5ddd\u7530\u5343\u7d18, \u6cb3\u91ce\u5f69\u5b50, \u677e\u7530\u57fa\u5f18, \u9ad8\u57ce\u4e00\u90ce, \u529b\u6b66\u96c4\u5e79, \u5ca9\u5c3e\u6d69\u662d, \u5c0f\u6751\u771f\u592e, \u5ddd\u53e3\u525b, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. \u80ba\u708e\u7403\u83cc\u306b\u3088\u308b\u591a\u767a\u7b4b\u81bf\u760d, \u8702\u7aa9\u7e54\u708e. \u7b2c87\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c60\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c65\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a. \u76ae\u819a\u30fb\u8edf\u90e8\u7d44\u7e54\u300068. 2017. (10\u670826-28\u65e5\uff0826\u65e5\u767a\u8868\uff09, \u9577\u5d0e\u770c\u9577\u5d0e\u5e02, \u9577\u5d0e\u30d6\u30ea\u30c3\u30af\u30db\u30fc\u30eb)<\/li>\n
          26. \u9ad8\u57ce\u4e00\u90ce, \u5ca9\u5c3e\u6d69\u662d, \u5ca1\u5c71\u662d\u5f66. \u5165\u9662\u60a3\u8005\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u767a\u75c7\u306e\u89e3\u6790. \u7b2c87\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c60\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c65\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a. \u611f\u67d3\u5bfe\u7b562\u300094. 2017. (10\u670826-28\u65e5\uff0826\u65e5\u767a\u8868\uff09, \u9577\u5d0e\u770c\u9577\u5d0e\u5e02, \u9577\u5d0e\u30d6\u30ea\u30c3\u30af\u30db\u30fc\u30eb)<\/li>\n
          27. Umekita K, Hashiba Y, Miyauchi S, Kubo K, Hidaka T, Okayama A. The Risk Factors of Developing Adult T Cell Leukemia (ATL) in Human T Cell Leukemia Virus Type 1 (HTLV-1) Positive Patients with Rheumatoid Arthritis in Endemic Area, Japan; A Retrospective Cohort Study. 2017 ACR\/ARHP ANNUAL MEETING. Presentation Number 273. 2017. (November 3-8(5presentation), San Diego Convention Center, San Diego, CA)<\/li>\n
          28. Umekita K, Miyauchi S, Iwao K, Rikitake M, Rikitake Y, Kawada C, Aizawa A, Kariya Y, Matsuda M, Kawaguchi T, Nomura H, Takajo I, Okayama A. Exosomes Derived from T Lymphocytes Enhance Expression of CXCL10 Induced by IFN-\u03b3 in Rheumatoid Arthritis Synovial Fibroblasts Via Pattern Recognition Receptor, RIG-I. 2017 ACR\/ARHP ANNUAL MEETING. Presentation Number 2427. 2017. (November 3-8(7presentation), San Diego Convention Center, San Diego, CA)<\/li>\n
          29. \u5c71\u672c\u6210\u90ce, \u5c71\u7530\u660e\u8f1d, \u6a4b\u5009\u60a0\u8f1d, \u6885\u6728\u4e00\u7f8e, \u4f50\u4f2f\u88d5\u4e8c, \u5ca1\u5c71\u662d\u5f66. \u81e8\u5e8a\u691c\u67fb\u6280\u5e2b\u306b\u3088\u308b\u718a\u672c\u5730\u9707\u3078\u306e\u533b\u7642\u652f\u63f4\u306e\u7d4c\u9a13\u3068\u8ab2\u984c. \u7b2c64\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u4e00\u822c\u6f14\u984c \u30c1\u30fc\u30e0\u533b\u7642\u30fb\u6559\u80b2, 165. 2017. (11\u670816-19\u65e5\uff0818\u65e5\u767a\u8868\uff09, \u4eac\u90fd\u5e9c\u4eac\u90fd\u5e02, \u56fd\u7acb\u4eac\u90fd\u56fd\u969b\u4f1a\u9928)<\/li>\n
          30. \u6885\u6728\u4e00\u7f8e, \u4fdd\u7530\u548c\u91cc, \u6a4b\u5009\u60a0\u8f1d, \u5c71\u7530\u660e\u8f1d, \u5c71\u672c\u6210\u90ce, \u91ce\u6751\u5275, \u6885\u5317\u90a6\u5f66, \u4e0b\u5cf6\u660c\u5e78, \u5ca1\u5c71\u662d\u5f66. \u91cd\u75c7\u71b1\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\u5019\u7fa4\uff08SFTS\uff09\u30a6\u30a4\u30eb\u30b9\u6297\u539f\u306e\u4f5c\u6210\u3068\u81e8\u5e8a\u5fdc\u7528. \u7b2c64\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u4e00\u822c\u6f14\u984c \u611f\u67d3\u75c7\u691c\u67fb2, 197. 2017. (11\u670816-19\u65e5\uff0818\u65e5\u767a\u8868\uff09, \u4eac\u90fd\u5e9c\u4eac\u90fd\u5e02, \u56fd\u7acb\u4eac\u90fd\u56fd\u969b\u4f1a\u9928)<\/li>\n
          31. \u798f\u5cf6\u7406\u7d17, \u529b\u6b66\u771f\u592e, \u9ad8\u57ce\u4e00\u90ce, \u5ddd\u7530\u5343\u7d18, \u5ca9\u5c3e\u6d69\u662d, \u76f8\u6fa4\u5f69\u5b50, \u5ddd\u53e3\u525b, \u6885\u5317\u90a6\u5f66, \u5b89\u500d\u5f18\u751f, \u5ca1\u5c71\u662d\u5f66. \u591a\u767a\u6d88\u5316\u7ba1\u6f70\u760d\u3092\u5448\u3057\u305f\u5168\u8eab\u6027\u30a8\u30ea\u30c6\u30de\u30c8\u30fc\u30c7\u30b9\u306e\u75c7\u4f8b. \u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u4e3b\u50ac \u7b2c320\u56de\u4e5d\u5dde\u5730\u65b9\u4f1a. \u521d\u671f\u7814\u4fee\u533b 4 (\u611f\u67d3\u75c7+\u30a2\u30ec\u30eb\u30ae\u30fc\u30fb\u81a0\u539f\u75c5). 2018. (1\u670820\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8 \u767e\u5e74\u8b1b\u5802)<\/li>\n
          32. \u798f\u7530\u771f\u5f13, \u9ad8\u57ce\u4e00\u90ce, \u4f50\u4f2f\u88d5\u4e8c, \u5e73\u539f\u5eb7\u5bff, \u5ca1\u5c71\u662d\u5f66. \u6c34\u9053\u86c7\u53e3\u6574\u6d41\u5668\u304c\u95a2\u4e0e\u3057\u305f\u3068\u8003\u3048\u3089\u308c\u305fM.paragordonae\/ M.gordonae\u306epseudo-outbreak. \u7b2c33\u56de\u65e5\u672c\u74b0\u5883\u611f\u67d3\u5b66\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u4e00\u822c\u6f14\u984c(\u53e3\u6f14) \u30a2\u30a6\u30c8\u30d6\u30ec\u30a4\u30af2\u3000O47-1. 2018. (2\u670823-24\u65e5(24\u65e5\u767a\u8868), \u6771\u4eac\u90fd\u54c1\u5ddd\u533a, \u30b0\u30e9\u30f3\u30c9\u30d7\u30ea\u30f3\u30b9\u30db\u30c6\u30eb\u65b0\u9ad8\u8f2a, \u56fd\u969b\u9928\u30d1\u30df\u30fc\u30eb, \u30b0\u30e9\u30f3\u30c9\u30d7\u30ea\u30f3\u30b9\u30db\u30c6\u30eb\u9ad8\u8f2a)<\/li>\n
          33. \u5c3e\u65b9\u7f8e\u5e78, \u4e95\u624b\u53e3\u6b66\u53f2, \u6851\u539f\u5f69, \u7530\u4e2d\u7f8e\u4e0e, \u9234\u6728\u5343\u4ee3\u5b50, \u5ddd\u8d8a\u52dd\u4e5f, \u9b3c\u585a\u4e45\u5145, \u5c71\u672c\u6210\u90ce, \u4e2d\u6751\u90fd\u82f1, \u77f3\u5ddd\u54f2\u61b2, \u5ca1\u5c71\u662d\u5f66. \u5fc3\u4e0d\u5168\u3067\u767a\u75c7\u3057\u305f\u5de8\u5927\u306a\u5fc3\u81d3\u6d77\u7dbf\u72b6\u8840\u7ba1\u816b. \u7b2c63\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a \u7b2c29\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a. \u4e00\u822c\u6f14\u984c 2 \u751f\u7406\u6a5f\u80fd 1, 6. 2018. (3\u67083\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8 \u767e\u5e74\u8b1b\u5802)<\/li>\n
          34. \u5c71\u8107\u5186\u83ef, \u5c71\u7530\u660e\u8f1d, \u6b66\u7530\u5c55\u5e78, \u677e\u6d66\u6210\u7f8e, \u4f50\u4f2f\u7950\u4e8c, \u6885\u6728\u4e00\u7f8e, \u5c71\u672c\u6210\u90ce, \u5ca1\u5c71\u662d\u5f66. \u8840\u6db2\u57f9\u990a\u6db2\u524d\u51e6\u7406\u30ad\u30c3\u30c8rapid BACpro \u2161\u304a\u3088\u3073Sepsityper kit\u3092\u7528\u3044\u305f\u8cea\u91cf\u5206\u6790\u88c5\u7f6e\u306b\u3088\u308b\u83cc\u7a2e\u76f4\u63a5\u540c\u5b9a\u6cd5\u306e\u6bd4\u8f03\u691c\u8a0e. \u7b2c63\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a \u7b2c29\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a. \u4e00\u822c\u6f14\u984c 5 \u611f\u67d3\u75c7\u30fb\u5fae\u751f\u7269 1, 24. 2018. (3\u67083\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8 \u767e\u5e74\u8b1b\u5802)<\/li>\n
          35. \u6cb3\u91ce\u514b\u6d77, \u6a4b\u5009\u60a0\u8f1d, \u9ad8\u6728\u899a, \u660e\u5229\u7f8e\u91cc, \u5c71\u672c\u6210\u90ce, \u4e45\u5bcc\u6728\u5eb8\u5b50, \u5ca1\u5c71\u662d\u5f66.
            \n\u9aa8\u9ac4\u4e2d\u306e\u30b9\u30de\u30c3\u30b8\u7d30\u80de\u96c6\u7c07\u304c\u8a3a\u65ad\u306b\u6709\u7528\u3067\u3042\u3063\u305f\u8840\u7ba1\u5185\u5927\u7d30\u80de\u578bB\u7d30\u80de\u30ea\u30f3\u30d1\u816b(IVLBCL). \u7b2c63\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a \u7b2c29\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a. \u4e00\u822c\u6f14\u984c 6 \u8840\u6db2 1, 28. 2018. (3\u67083\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8 \u767e\u5e74\u8b1b\u5802)<\/li>\n
          36. \u4e45\u4fdd\u548c\u7fa9, \u6a4b\u5834\u5f25\u751f, \u9ed2\u7530\u5b8f, \u65e5\u9ad8\u5229\u5f66. \u5f53\u9662\u306e\u30c7\u30ce\u30b9\u30de\u30d6\u306e\u6cbb\u7642\u52b9\u679c\u306b\u3064\u3044\u3066. \u7b2c55\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u4e00\u822c\u6f14\u984c1\u300cRA\u300d O-1-1. 2018. (3\u67083-4\u65e5\uff083\u65e5\u767a\u8868\uff09, \u6c96\u7e04\u770c\u90a3\u8987\u5e02, \u6c96\u7e04\u770c\u5e02\u753a\u6751\u81ea\u6cbb\u4f1a\u9928)<\/li>\n
          37. \u6a4b\u5834\u5f25\u751f, \u65e5\u9ad8\u5229\u5f66, \u4e45\u4fdd\u548c\u7fa9, \u9ed2\u7530\u5b8f. \u5f53\u9662\u306b\u304a\u3051\u308b75\u6b73\u4ee5\u4e0a\u9ad8\u9f62\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u306b\u5bfe\u3059\u308b\u30a4\u30b0\u30e9\u30c1\u30e2\u30c9\u306e\u6cbb\u7642\u52b9\u679c\u306b\u3064\u3044\u3066. \u7b2c55\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u4e3b\u984c1-1\u300c\u5bdb\u89e3\u3092\u76ee\u6307\u3059RA\u533b\u7642\u300d S-1-2. 2018. (3\u67083-4\u65e5\uff083\u65e5\u767a\u8868\uff09, \u6c96\u7e04\u770c\u90a3\u8987\u5e02, \u6c96\u7e04\u770c\u5e02\u753a\u6751\u81ea\u6cbb\u4f1a\u9928)<\/li>\n
          38. \u65e5\u9ad8\u5229\u5f66, \u6a4b\u5834\u5f25\u751f, \u4e45\u4fdd\u548c\u7fa9, \u9ed2\u7530\u5b8f, \u529b\u6b66\u771f\u592e, \u5ddd\u7530\u5343\u7d18, \u5742\u53e3\u7fd4\u592a, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u5f53\u9662\u306b\u304a\u3051\u308b\u81a0\u539f\u75c5\u5408\u4f75\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u306b\u5bfe\u3059\u308b\u30a2\u30d0\u30bf\u30bb\u30d7\u30c8\u306e\u6cbb\u7642\u52b9\u679c\u306b\u3064\u3044\u3066. \u7b2c55\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u4e3b\u984c1-2\u300c\u5bdb\u89e3\u3092\u76ee\u6307\u3059RA\u533b\u7642\u300d S-1-12. 2018. (3\u67083-4\u65e5\uff083\u65e5\u767a\u8868\uff09, \u6c96\u7e04\u770c\u90a3\u8987\u5e02, \u6c96\u7e04\u770c\u5e02\u753a\u6751\u81ea\u6cbb\u4f1a\u9928)<\/li>\n
          39. \u6728\u6751\u8ce2\u4fca, \u76f8\u6fa4\u5f69\u5b50, \u5bae\u5185\u4fca\u4e00, \u5ddd\u7530\u5343\u7d18, \u529b\u6b66\u96c4\u5e79, \u529b\u6b66\u771f\u592e, \u5ca9\u5c3e\u6d69\u662d, \u5ddd\u53e3\u525b, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u7d4c\u904e\u4e2d\u306b\u809d\u7d2b\u6591\u75c5\u306e\u5408\u4f75\u304c\u8003\u3048\u3089\u308c\u305f\u30eb\u30fc\u30d7\u30b9\u814e\u708e\u306e\u4e00\u4f8b. \u7b2c55\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u30dd\u30b9\u30bf\u30fc\u30bb\u30c3\u30b7\u30e7\u30f31\u300cSLE\u300d P-1-4. 2018. (3\u67083-4\u65e5\uff084\u65e5\u767a\u8868\uff09, \u6c96\u7e04\u770c\u90a3\u8987\u5e02, \u6c96\u7e04\u770c\u5e02\u753a\u6751\u81ea\u6cbb\u4f1a\u9928)<\/li>\n
          40. \u5ddd\u7530\u5343\u7d18, \u5ddd\u53e3\u525b, \u5ca9\u5c3e\u6d69\u662d, \u529b\u6b66\u771f\u592e, \u6cb3\u91ce\u5f69\u5b50, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u8178\u7ba1\u56a2\u80de\u6027\u6c17\u816b\u75c7\u3092\u5408\u4f75\u3057\u305fTIF1-\u03b3\u967d\u6027\u76ae\u819a\u7b4b\u708e\u306e1\u4f8b. \u7b2c55\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u30dd\u30b9\u30bf\u30fc\u30bb\u30c3\u30b7\u30e7\u30f36\u300cPM\/DM, IgG4\u306a\u3069\u300d P-6-7. 2018. (3\u67083-4\u65e5\uff084\u65e5\u767a\u8868\uff09, \u6c96\u7e04\u770c\u90a3\u8987\u5e02, \u6c96\u7e04\u770c\u5e02\u753a\u6751\u81ea\u6cbb\u4f1a\u9928)<\/li>\n<\/ol>\n

            \u3010\u7814\u7a76\u4f1a\u767a\u8868\u3011<\/h4>\n
              \n
            1. \u5bae\u5185\u4fca\u4e00, \u5ddd\u7530\u5343\u7d18, \u529b\u6b66\u96c4\u5e79, \u5ca9\u5c3e\u6d69\u662d, \u529b\u6b66\u771f\u592e, \u76f8\u6fa4\u5f69\u5b50, \u5ddd\u53e3\u525b, \u677e\u7530\u57fa\u5f18, \u6885\u5317\u90a6\u5f66, \u9ad9\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u80ba\u75c5\u5909\u304c\u5148\u884c\u3057\u3001\u672b\u68a2\u795e\u7d4c\u304a\u3088\u3073 \u8033\u9f3b\u75c7\u72b6\u306e\u51fa\u73fe\u306b\u3088\u308a\u8a3a\u65ad\u3057\u5f97\u305fANCA\u95a2\u9023\u8840\u7ba1\u708e\u306e\u4e00\u4f8b. \u5bae\u5d0e\u770c\u8840\u7ba1\u708e\u30bb\u30df\u30ca\u30fc. \u4e00\u822c\u6f14\u984c 2. 2017. (5\u670812\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u89b3\u5149\u30db\u30c6\u30eb)<\/li>\n
            2. \u677e\u7530\u57fa\u5f18, \u9ad8\u57ce\u4e00\u90ce, \u5ca9\u5c3e\u6d69\u662d, \u6cb3\u91ce\u5f69\u5b50, \u4eee\u5c4b\u88d5\u7f8e, \u5bae\u5185\u4fca\u4e00, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u751f\u7269\u5b66\u7684\u88fd\u5264\u4f7f\u7528\u4e2d\u306e\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u304a\u3051\u308b\u5165\u9662\u6cbb\u7642\u3092\u8981\u3057\u305f\u611f\u67d3\u75c7\u306e\u691c\u8a0e. \u7b2c14\u56de\u5bae\u5d0e\u81a0\u539f\u75c5\u30ea\u30a6\u30de\u30c1\u6cbb\u7642\u7814\u7a76\u4f1a. 2017. (6\u67082\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u89b3\u5149\u30db\u30c6\u30eb)<\/li>\n
            3. \u6728\u6751\u8ce2\u4fca, \u5ca9\u5c3e\u6d69\u662d. \u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6A\u578b\u3092\u6cbb\u7642\u5f8c\u3082\u767a\u71b1\u304c\u9077\u5ef6\u3057\u3001\u6025\u6027HIV\u611f\u67d3\u3068\u8a3a\u65ad\u3055\u308c\u305f1\u4f8b. \u7b2c14\u56de\u5148\u7aef\u533b\u7642\u30bb\u30df\u30ca\u30fc. \u4e00\u822c\u6f14\u984c 3. 2016. (7\u670815\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u30db\u30c6\u30eb\uff2a\uff21\uff2c\u30b7\u30c6\u30a3\u5bae\u5d0e)<\/li>\n
            4. \u91d1\u4e38\u548c\u6a39, \u5bae\u5185\u4fca\u4e00. \u810a\u9ac4\u75c5\u5909\u3092\u4f34\u3063\u305f\u30b7\u30a7\u30fc\u30b0\u30ec\u30f3\u75c7\u5019\u7fa4\u306e\u4e00\u4f8b. \u7b2c14\u56de\u5148\u7aef\u533b\u7642\u30bb\u30df\u30ca\u30fc. \u4e00\u822c\u6f14\u984c 7. 2017. (7\u670815\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u30db\u30c6\u30eb\uff2a\uff21\uff2c\u30b7\u30c6\u30a3\u5bae\u5d0e)<\/li>\n
            5. \u6885\u5317\u90a6\u5f66. HTLV-1\u967d\u6027\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u304a\u3051\u308b\u30c8\u30b7\u30ea\u30ba\u30de\u30d6\u306e\u4f7f\u7528\u7d4c\u9a13. \u7b2c3\u56de\u5bae\u5d0e\u770cIL\uff0d6\u7814\u7a76\u4f1a. \u4e00\u822c\u6f14\u984c. 2017. (9\u67081\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u89b3\u5149\u30db\u30c6\u30eb)<\/li>\n
            6. \u4e45\u4fdd\u548c\u7fa9. \u5f53\u9662\u3067\u306e\u30a2\u30c0\u30ea\u30e0\u30de\u30d6\uff08ADA\uff09\u306b\u304a\u3051\u308b\u30e1\u30c8\u30c8\u30ec\u30ad\u30b5\u30fc\u30c8\uff08MTX\uff09\u81f3\u9069\u7528\u91cf\u306e\u691c\u8a0e\u306b\u3064\u3044\u3066. \u5bae\u5d0eRA\/SpA\u3000ExpertMeeting. RA\u30bb\u30c3\u30b7\u30e7\u30f3. 2017. (9\u670813\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u89b3\u5149\u30db\u30c6\u30eb)<\/li>\n
            7. \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u6a4b\u5834\u5f25\u751f, \u65e5\u9ad8\u5229\u5f66, \u5ca1\u5c71\u662d\u5f66. \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u6cbb\u7642\u4e2d\u306b\u7d4c\u9a13\u3057\u305f\u6210\u4ebaT\u7d30\u80de\u6027\u767d\u8840\u75c52\u4f8b\u306e\u5831\u544a. \u7b2c1\u56de\u4e5d\u5dde\u81a0\u539f\u75c5\u96e3\u6cbb\u6027\u75c5\u614b\u6cbb\u7642\u7814\u7a76\u4f1a. Session\u2161\uff1a\u4e00\u822c\u6f14\u984c\u2461\u3000\u6f14\u984c\u2464. 2017. (12\u670823\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u897f\u65e5\u672c\u65b0\u805e\u4f1a\u9928)<\/li>\n
            8. \u5ca9\u5c3e\u6d69\u662d, \u677e\u7530\u57fa\u5f18, \u5ddd\u7530\u5343\u7d18, \u529b\u6b66\u771f\u592e, \u76f8\u6fa4\u5f69\u5b50, \u5ddd\u53e3\u525b, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u795e\u7d4c\u8a8d\u77e5\u969c\u5bb3\u3092\u5448\u3057\u305fHIV\u611f\u67d3\u75c7. \u7b2c37\u56de\u5bae\u5d0e\u611f\u67d3\u75c7\u7814\u7a76\u4f1a. \u4e00\u822c\u6f14\u984c. 2018. (2\u670810\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u30db\u30c6\u30eb\u30b9\u30ab\u30a4\u30bf\u30ef\u30fc)<\/li>\n
            9. \u56f3\u5e2b\u572d\u4e00, \u65e5\u9ad8\u4e9c\u7d00\u5b50, \u82b9\u6fa4\u9ebb\u571f\u9999, \u77e2\u91ce\u662d\u4ee3, \u6771\u539f\u7f8e\u7531\u7d00, \u6a4b\u5834\u5f25\u751f, \u4e45\u4fdd\u548c\u7fa9, \u65e5\u9ad8\u5229\u5f66. \u30a2\u30c0\u30ea\u30e0\u30de\u30d6\u65b0\u898f\u88fd\u5264\u5909\u66f4\u306b\u4f34\u3046\u6ce8\u5c04\u6642\u75bc\u75db\u8efd\u6e1b\u306b\u95a2\u3059\u308b\u7814\u7a76. \u7b2c33\u56de\u5bae\u5d0e\u770c\u30ea\u30a6\u30de\u30c1\u7814\u7a76\u4f1a \u7b2c26\u56de\u5bae\u5d0e\u30ea\u30a6\u30de\u30c1\u306e\u30b1\u30a2\u7814\u7a76\u4f1a. \u2160. \u4e00\u822c\u6f14\u984c 1. 2018. (2\u670817\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, MRTmicc)<\/li>\n
            10. \u6a4b\u5834\u5f25\u751f, \u4e45\u4fdd\u548c\u7fa9, \u9ed2\u7530\u5b8f, \u65e5\u9ad8\u5229\u5f66. \u5f53\u9662\u306b\u304a\u3051\u308b\u9ad8\u9f62\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u306b\u5bfe\u3059\u308b\u30a4\u30b0\u30e9\u30c1\u30e2\u30c9\u306e\u6cbb\u7642\u52b9\u679c. \u7b2c33\u56de\u5bae\u5d0e\u770c\u30ea\u30a6\u30de\u30c1\u7814\u7a76\u4f1a. \u7b2c26\u56de\u5bae\u5d0e\u30ea\u30a6\u30de\u30c1\u306e\u30b1\u30a2\u7814\u7a76\u4f1a. \u2161. \u4e00\u822c\u6f14\u984c 2. 2018. (2\u670817\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, MRTmicc)<\/li>\n
            11. \u4e45\u4fdd\u548c\u7fa9, \u6a4b\u5834\u5f25\u751f, \u9ed2\u7530\u5b8f, \u65e5\u9ad8\u5229\u5f66. \u30a2\u30c0\u30ea\u30e0\u30de\u30d6\u306e\u5b9f\u81e8\u5e8a\u4e0b\u3067\u306eMTX\u6307\u6458\u7528\u91cf\uff0d\u5f53\u9662\u306b\u304a\u3051\u308b\u691c\u8a0e\uff0d. \u7b2c33\u56de\u5bae\u5d0e\u770c\u30ea\u30a6\u30de\u30c1\u7814\u7a76\u4f1a. \u7b2c26\u56de\u5bae\u5d0e\u30ea\u30a6\u30de\u30c1\u306e\u30b1\u30a2\u7814\u7a76\u4f1a. \u2161. \u4e00\u822c\u6f14\u984c 2. 2018. (2\u670817\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, MRTmicc)<\/li>\n
            12. \u5e73\u539f\u5eb7\u5bff. \u30ab\u30eb\u30d0\u30da\u30cd\u30e0\u7cfb\u6297\u83cc\u85ac\u9069\u6b63\u4f7f\u7528\u306e\u8a55\u4fa1\u3068\u8ab2\u984c. \u7b2c22\u56de\u4e5d\u5dde\u5316\u5b66\u7642\u6cd5\u7814\u7a76\u4f1a. \u4e00\u822c\u8b1b\u6f14 \u6f14\u984c 1. 2018. (2\u670817\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u30db\u30c6\u30eb\u30bb\u30f3\u30c8\u30e9\u30fc\u30b6\u535a\u591a)<\/li>\n<\/ol>\n

              \u3010\u8b1b\u6f14\u30fb\u30bb\u30df\u30ca\u30fc\u3011<\/h4>\n
                \n
              1. \u9ad8\u57ce\u4e00\u90ce. \u6a19\u6e96\u4e88\u9632\u7b56\u3068\u8077\u696d\u611f\u67d3\u9632\u6b62\u3000\uff5e\u60a3\u8005\u3068\u81ea\u5206\u3092\u5b88\u308b\u305f\u3081\u306b\u306f\uff5e. \u5e73\u621029\u5e74\u5ea6\u65b0\u898f\u63a1\u7528\u8005\u30aa\u30ea\u30a8\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3. 2016. (4\u67083\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
              2. \u9ad8\u57ce\u4e00\u90ce, \u798f\u7530\u771f\u5f13. \u611f\u67d3\u5bfe\u7b56\u306b\u3064\u3044\u3066. \u5e73\u621029\u5e74\u5ea6\u533b\u54e1\uff08\u7814\u4fee\u533b\uff09\u30aa\u30ea\u30a8\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3. 2016. (4\u67084\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
              3. \u9ad8\u57ce\u4e00\u90ce, \u798f\u7530\u771f\u5f13. \u9662\u5185\u611f\u67d3\u5bfe\u7b56. \u5e73\u621029\u5e74\u5ea6\u533b\u5b66\u79d11\u5e74\u751f\u5b66\u5185\u65e9\u671f\u4f53\u9a13\u5b9f\u7fd2. 2017. (4\u670828\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8)<\/li>\n
              4. \u6885\u5317\u90a6\u5f66. \u30ea\u30a6\u30de\u30c1\u6cbb\u7642\u3092\u5b89\u5fc3\u3057\u3066\u7d9a\u3051\u308b\u305f\u3081\u306b. \u30ea\u30a6\u30de\u30c1\u533b\u7642\u8b1b\u6f14\u4f1a. \u6f14\u984c \u7b2c2\u90e8. 2017. (5\u670821\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5e02\u7dcf\u5408\u798f\u7949\u4fdd\u5065\u30bb\u30f3\u30bf\u30fc)<\/li>\n
              5. \u6885\u5317\u90a6\u5f66. \u751f\u7269\u5b66\u7684\u88fd\u5264\u4f7f\u7528\u306b\u304a\u3051\u308b\u30dd\u30a4\u30f3\u30c8\uff5e\u5185\u79d1\u306e\u7acb\u5834\u304b\u3089\uff5e. \u5bae\u5d0e\u773c\u708e\u75c7\u30bb\u30df\u30ca\u30fc. \u8b1b\u6f14\u30001. 2017. (6\u670824\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, MRT\u3000micc)<\/li>\n
              6. \u9ad8\u57ce\u4e00\u90ce. \u57fa\u672c\u7684\u81e8\u5e8a\u624b\u6280[\u885b\u751f\u7684\u624b\u6d17\u3044]. \u5e73\u621029\u5e74\u5ea6\u7dcf\u5408\u533b\u5b66\u30fb\u81e8\u5e8a\u8a3a\u65ad\u5b66(\u5b9f\u7fd2)\u30aa\u30ea\u30a8\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3. 2017. (7\u670810\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8)<\/li>\n
              7. \u6885\u5317\u90a6\u5f66. \u76ae\u819a\u7b4b\u708e\u306e\u81e8\u5e8a\u50cf. \u708e\u75c7\u6027\u75be\u60a3\u3092\u8003\u3048\u308b\u4f1a. 2017. (7\u670820\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
              8. \u5ca1\u5c71\u662d\u5f66. \u611f\u67d3\u75c7\u57fa\u790e\uff08\u611f\u67d3\u75c7\u3068\u6613\u611f\u67d3\u6027\uff09. \u5e73\u621029\u5e74\u5ea6\u30bb\u30ec\u30af\u30c8\u30b3\u30fc\u30b9IC\u30d7\u30ed\u30b0\u30e9\u30e0. 2017. (7\u670828\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
              9. \u9ad8\u57ce\u4e00\u90ce. \u75c5\u9662\u3067\u554f\u984c\u3068\u306a\u308b\u8010\u6027\u83cc. \u5e73\u621029\u5e74\u5ea6\u30bb\u30ec\u30af\u30c8\u30b3\u30fc\u30b9IC\u30d7\u30ed\u30b0\u30e9\u30e0. 2017. (9\u67081\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
              10. \u9ad8\u57ce\u4e00\u90ce. \u8077\u696d\u611f\u67d3\u9632\u6b62\u5bfe\u7b56(4\u7a2e\u30a6\u30a4\u30eb\u30b9\u3001\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6). \u5e73\u621029\u5e74\u5ea6\u30bb\u30ec\u30af\u30c8\u30b3\u30fc\u30b9IC\u30d7\u30ed\u30b0\u30e9\u30e0. 2017. (9\u67081\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
              11. \u9ad8\u57ce\u4e00\u90ce. \u5bae\u5d0e\u5927\u5b66\u3067\u306e\u611f\u67d3\u5bfe\u7b56\u306e\u73fe\u72b6. JICA TRAINING. 2017. (9\u670819\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
              12. \u6885\u5317\u90a6\u5f66. \u30ea\u30a6\u30de\u30c1\u306e\u6700\u8fd1\u306e\u8a71\u984c\uff5e\u9451\u5225\u8a3a\u65ad\u3092\u542b\u3081\u3066\uff5e. \u65e5\u5411RA-Meeting. \u7279\u5225\u8b1b\u6f14. 2017. (9\u670829\u65e5, \u5bae\u5d0e\u770c\u65e5\u5411\u5e02, \u30d9\u30eb\u30d5\u30a9\u30fc\u30c8\u65e5\u5411)<\/li>\n
              13. \u9ad8\u57ce\u4e00\u90ce. \u8077\u696d\u611f\u67d3\u9632\u6b62\u5bfe\u7b56(\u7d50\u6838\u3001HIV\u3001HBV). \u5e73\u621029\u5e74\u5ea6\u30bb\u30ec\u30af\u30c8\u30b3\u30fc\u30b9IC\u30d7\u30ed\u30b0\u30e9\u30e0. 2017. (9\u670829\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
              14. \u9ad8\u57ce\u4e00\u90ce. \u9662\u5185\u611f\u67d3\u5bfe\u7b56\uff0d\u60a3\u8005\u3055\u3093\u3068\u533b\u7642\u30b9\u30bf\u30c3\u30d5\u3092\u5b88\u308b\u305f\u3081\u306b\uff0d. \u7b2c19\u56de\u5357\u90a3\u73c2\u611f\u67d3\u5bfe\u7b56\u30bb\u30df\u30ca\u30fc. 2017. (10\u67083\u65e5, \u5bae\u5d0e\u770c\u65e5\u5357\u5e02, \u5bae\u5d0e\u770c\u7acb\u65e5\u5357\u75c5\u9662)<\/li>\n
              15. \u5ca1\u5c71\u662d\u5f66. \u611f\u67d3\u5bfe\u7b56\u306b\u95a2\u3059\u308b\u3053\u3068. \u5e73\u621029\u5e74\u5ea6 \u7b2c1\u56de\u5c02\u9580\u533b\u5171\u901a\u8b1b\u7fd2\u4f1a\u3000\u533b\u7642\u502b\u7406\u30fb\u611f\u67d3\u5bfe\u7b56. \u8b1b\u6f14\u2161\u300c\u611f\u67d3\u5bfe\u7b56\u300d. 2017. (10\u670816\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u9928<\/li>\n
              16. \u9ad8\u57ce\u4e00\u90ce. \u5f53\u9662\u306e\u611f\u67d3\u5bfe\u7b56\u30d6\u30e9\u30c3\u30b7\u30e5\u30a2\u30c3\u30d7. \u5e73\u621029\u5e74\u5ea6\u533b\u7642\u5b89\u5168\u7ba1\u7406\u30fb\u611f\u67d3\u5bfe\u7b56\u8b1b\u6f14\u4f1a. 2017. (10\u670820\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
              17. \u9ad8\u57ce\u4e00\u90ce. \u611f\u67d3\u5bfe\u7b56\u3068\u533b\u7642\u5b89\u5168\u306e\u4f4f\u307f\u5206\u3051\u3068\u5354\u50cd. \u5e73\u621029\u5e74\u5ea6\u30a2\u30c9\u30d0\u30f3\u30b9\u30c9\u30bb\u30df\u30ca\u30fc2.0. 2018. (2\u670828\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662)<\/li>\n
              18. \u5ca1\u5c71\u662d\u5f66. SFTS\u3068\u306f. SFTS\u8b1b\u6f14\u4f1a. 2018. (3\u670810\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u9ad8\u5ca1\u798f\u7949\u4fdd\u5065\u30bb\u30f3\u30bf\u30fc\u7a46\u5712\u9928)<\/li>\n<\/ol>\n

                \u3010\u305d\u306e\u4ed6\u3011<\/h4>\n
                  \n
                1. \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. HTLV-1\u611f\u67d3\u8005\u304a\u3088\u3073\u95a2\u9023\u75be\u60a3\u60a3\u8005\u306b\u5408\u4f75\u3059\u308b\u708e\u75c7\u6027\u75be\u60a3\u306e\u708e\u75c7\u4fc3\u9032\u56e0\u5b50\u306e\u63a2\u7d22. \u81e8\u5e8a\u30b2\u30ce\u30e0\u60c5\u5831\u7d71\u5408\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u6574\u5099\u4e8b\u696d\u3000\u300c\u30d2\u30c8\u3068\u30a6\u30a4\u30eb\u30b9\u306e\u30b2\u30ce\u30e0\u60c5\u5831\u3068\u81e8\u5e8a\u60c5\u5831\u306e\u7d71\u5408\u306b\u3088\u308bHTLV-1\u95a2\u9023\u75be\u60a3\u306e\u8a3a\u7642\u652f\u63f4\u5168\u56fd\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u306e\u78ba\u7acb\u300d\u73ed\u4f1a\u8b70. 2017. (8\u670820\u65e5, \u5927\u962a\u5e9c\u679a\u65b9\u5e02, \u95a2\u897f\u533b\u79d1\u5927\u5b66)<\/li>\n
                2. \u5ca1\u5c71\u662d\u5f66. \u96e3\u6cbb\u6027\u30ea\u30a6\u30de\u30c1\u6027\u75be\u60a3\u60a3\u8005\u306b\u304a\u3051\u308bHTLV-1\u967d\u6027\u8005\u306e\u5bfe\u5fdc\u306b\u3064\u3044\u3066. \u5e73\u621029\u5e74\u5ea6\u3000\u7b2c\uff11\u56de\u5c71\u91ce\u73ed\u5408\u540c\u73ed\u4f1a\u8b70. 2017. (10\u67089\u65e5, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u30db\u30c6\u30eb\u30b0\u30e9\u30f3\u30c9\u30a2\u30fc\u30af\u534a\u8535\u9580)<\/li>\n
                3. \u6885\u5317\u90a6\u5f66. HTLV-1\u611f\u67d3\u8005\u304a\u3088\u3073\u95a2\u9023\u75be\u60a3\u60a3\u8005\u306b\u5408\u4f75\u3059\u308b\u708e\u75c7\u6027\u75be\u60a3\u306e\u708e\u75c7\u4fc3\u9032\u56e0\u5b50\u306e\u63a2\u7d22. \u5e73\u621029\u5e74\u5ea6\u5c71\u91ce\u73ed\u30fb\u677e\u7530\u73ed\u30fb\u5408\u540c\u73ed\u4f1a\u8b70. \u300c\u30d2\u30c8\u3068\u30a6\u30a4\u30eb\u30b9\u30b2\u30ce\u30e0\u60c5\u5831\u3068\u81e8\u5e8a\u60c5\u5831\u306e\u7d71\u5408\u306b\u3088\u308bHTLV-1\u95a2\u9023\u75be\u60a3\u306e\u8a3a\u7642\u652f\u63f4\u5168\u56fd\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u306e\u78ba\u7acb\u300d(\u677e\u7530\u73ed)\u73ed\u4f1a\u8b70. 2018. (2\u670827\u65e5, \u4eac\u90fd\u5e9c\u4eac\u90fd\u5e02, KKR\u4eac\u90fd\u304f\u306b\u8358)<\/li>\n<\/ol>\n

                  –<\/p>\n

                  \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/a><\/div>\n

                  C. \u305d\u306e\u4ed6<\/h3>\n
                    \n
                  1. \u9ad8\u57ce\u4e00\u90ce. \u30a8\u30b3\u30fc\u30fb\u30ea\u30ec\u30fc\u3000\u300c\u57f7\u4e8b\u300d\u306e\u7cbe\u795e. \u65e5\u5dde\u91ab\u4e8b. 2017; 814: 6.(6\u670810\u65e5)<\/li>\n
                  2. \u9ad8\u57ce\u4e00\u90ce. \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u3060\u3088\u308a\u3000\u5185\u79d1\u5b66\u8b1b\u5ea7\u2015\u514d\u75ab\u611f\u67d3\u75c5\u614b\u5b66\u5206\u91ce\u2015. \u65e5\u5dde\u91ab\u4e8b. 2017; 817: 9.(9\u670810\u65e5)<\/li>\n
                  3. \u6885\u5317\u90a6\u5f66. \u30ea\u30a6\u30de\u30c1\u6cbb\u7642\u3092\u5b89\u5fc3\u3057\u3066\u7d9a\u3051\u308b\u305f\u3081\u306b. \u306f\u307e\u3086\u3046. 2017; 59: 8-9.(9\u670830\u65e5)<\/li>\n
                  4. \u9ad8\u57ce\u4e00\u90ce. \u81e8\u5e8a\u691c\u67fb\u5c02\u9580\u533b\u3068\u3057\u3066. JACLaP NEWS. 2017; 131: 4. (10\u6708)<\/li>\n
                  5. \u9ad8\u57ce\u4e00\u90ce. \u533b\u5c40\u3001\u7814\u7a76\u5ba4\u3060\u3088\u308a\u3000\u5185\u79d1\u5b66\u8b1b\u5ea7\u514d\u75ab\u611f\u67d3\u75c5\u614b\u5b66\u5206\u91ce. \u7be0\u61f8 \u7b2c28\u53f7. 2017.(12\u670822\u65e5)<\/li>\n<\/ol>\n

                     <\/p>\n

                    \u3010\u5b66\u4f1a\u4e3b\u50ac\u7b49\u3011<\/strong><\/p>\n

                      <\/ol>\n
                        <\/ol>\n

                        –<\/p>\n

                        \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/a><\/div>\n

                        D. \u7279\u8a31\u51fa\u9858<\/h3>\n

                        –<\/p>\n

                        \"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a><\/a><\/div>\n

                        \u5185\u8a33\u6570\uff082020\u5e7410\u67085\u65e5\u6642\u70b9\uff09<\/span><\/h2>\n

                        A.\u8ad6\u6587\uff1a\u8457\u66f8(0), \u539f\u8457(6), \u75c7\u4f8b\u5831\u544a\uff08\u8ad6\u6587\uff09(9), \u7dcf\u8aac\uff084\uff09
                        \nB.\u767a\u8868\uff1a\u5b66\u4f1a\u767a\u8868\uff0840\uff09, \u7814\u7a76\u4f1a\u767a\u8868\uff0812\uff09, \u8b1b\u6f14\u30fb\u30bb\u30df\u30ca\u30fc\uff0818\uff09, \u305d\u306e\u4ed6\uff083\uff09
                        \nC.\u305d\u306e\u4ed6\uff085\uff09
                        \nD.\u7279\u8a31\u51fa\u9858\uff080\uff09<\/p>\n","protected":false},"excerpt":{"rendered":"

                        A. \u8ad6\u6587 \u3010\u8457\u66f8\u3011 \u3010\u539f\u8457\u3011 Mori S, Yoshitama T, Hidaka T, Sakai F, Hasegawa M, Hashiba Y, Suematsu E, Tatsukawa H, Mizoka […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false},"categories":[9,11],"tags":[],"_links":{"self":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts\/288"}],"collection":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/comments?post=288"}],"version-history":[{"count":0,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts\/288\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/media?parent=288"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/categories?post=288"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/tags?post=288"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}